{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:00:45Z","timestamp":1790758845169,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T00:00:00Z","timestamp":1497312000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T00:00:00Z","timestamp":1497312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR44883"],"award-info":[{"award-number":["R01 AR44883"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13075-017-1356-3","type":"journal-article","created":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T15:22:49Z","timestamp":1497367369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Anti-connective tissue growth factor (CTGF\/CCN2) monoclonal antibody attenuates skin fibrosis in mice models of systemic sclerosis"],"prefix":"10.1186","volume":"19","author":[{"given":"Katsunari","family":"Makino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz","family":"Stawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Lipson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Leask","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9550-7178","authenticated-orcid":false,"given":"Maria","family":"Trojanowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,13]]},"reference":[{"key":"1356_CR1","doi-asserted-by":"publisher","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","volume":"1","author":"Y Allanore","year":"2015","unstructured":"Allanore Y, Simms R, Distler O, Trojanowska M, Pope J, Denton CP, et al. Systemic sclerosis. Nat Rev Dis Primers. 2015;1:15002.","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"1356_CR2","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","volume":"10","author":"R Lafyatis","year":"2014","unstructured":"Lafyatis R. Transforming growth factor \u03b2\u2013at the centre of systemic sclerosis. Nat Rev Rheumatol. 2014;10(12):706\u201319.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"1356_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s12079-009-0037-7","volume":"3","author":"A Leask","year":"2009","unstructured":"Leask A, Parapuram SK, Shi-Wen X, Abraham DJ. Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease? J Cell Commun Signal. 2009;3(2):89\u201394.","journal-title":"J Cell Commun Signal"},{"issue":"19","key":"1356_CR4","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1007\/s00018-011-0782-7","volume":"68","author":"F Hall-Glenn","year":"2011","unstructured":"Hall-Glenn F, Lyons KM. Roles for CCN2 in normal physiological processes. Cell Mol Life Sci. 2011;68(19):3209\u201317.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"1356_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K","volume":"181","author":"T Mori","year":"1999","unstructured":"Mori T, Kawara S, Shinozaki M, Hayashi N, Kakinuma T, Igarashi A, et al. Role and interaction of connective tissue growth factor with transforming growth factor-\u03b2 in persistent fibrosis: a mouse fibrosis model. J Cell Physiol. 1999;181(1):153\u20139.","journal-title":"J Cell Physiol"},{"issue":"1","key":"1356_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/art.30074","volume":"63","author":"S Liu","year":"2011","unstructured":"Liu S, Shi-wen X, Abraham DJ, Leask A. CCN2 is required for bleomycin-induced skin fibrosis in mice. Arthritis Rheum. 2011;63(1):239\u201346.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1356_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.biochi.2010.11.010","volume":"93","author":"L Kular","year":"2011","unstructured":"Kular L, Pakradouni J, Kitabgi P, Laurent M, Martinerie C. The CCN family: a new class of inflammation modulators? Biochimie. 2011;93(3):377\u201388.","journal-title":"Biochimie"},{"issue":"3","key":"1356_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.vph.2013.01.004","volume":"58","author":"M Ponticos","year":"2013","unstructured":"Ponticos M. Connective tissue growth factor (CCN2) in blood vessels. Vascul Pharmacol. 2013;58(3):189\u201393.","journal-title":"Vascul Pharmacol"},{"issue":"5","key":"1356_CR9","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1002\/art.27382","volume":"62","author":"S Sonnylal","year":"2010","unstructured":"Sonnylal S, Shi-Wen X, Leoni P, Naff K, Van Pelt CS, Nakamura H, et al. Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis. Arthritis Rheum. 2010;62(5):1523\u201332.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1356_CR10","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1002\/art.39287","volume":"67","author":"LM Rice","year":"2015","unstructured":"Rice LM, Ziemek J, Stratton EA, McLaughlin SR, Padilla CM, Mathes AL, et al. A longitudinal biomarker for the extent of skin disease in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheumatol. 2015;67(11):3004\u201315.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"1356_CR11","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/1523-1747.ep12345771","volume":"106","author":"A Igarashi","year":"1996","unstructured":"Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, Fujimoto M, et al. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol. 1996;106(4):729\u201333.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"1356_CR12","first-page":"149","volume":"27","author":"S Sato","year":"2000","unstructured":"Sato S, Nagaoka T, Hasegawa M, Tamatani T, Nakanishi T, Takigawa M, et al. Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. J Rheumatol. 2000;27(1):149\u201354.","journal-title":"J Rheumatol"},{"issue":"43","key":"1356_CR13","doi-asserted-by":"publisher","first-page":"41728","DOI":"10.1074\/jbc.M305019200","volume":"278","author":"A Holmes","year":"2003","unstructured":"Holmes A, Abraham DJ, Chen Y, Denton C, Shi-wen X, Black CM, et al. Constitutive connective tissue growth factor expression in scleroderma fibroblasts is dependent on Sp1. J Biol Chem. 2003;278(43):41728\u201333.","journal-title":"J Biol Chem"},{"issue":"7","key":"1356_CR14","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/qjmed\/hci078","volume":"98","author":"M Dziadzio","year":"2005","unstructured":"Dziadzio M, Usinger W, Leask A, Abraham D, Black CM, Denton C, et al. N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma. QJM. 2005;98(7):485\u201392.","journal-title":"QJM"},{"key":"1356_CR15","doi-asserted-by":"crossref","unstructured":"Makino K, Makino T, Stawski L, Mantero JC, Lafyatis R, Simms R, et al. Blockade of PDGF receptors by crenolanib has therapeutic effect in patient fibroblasts and in preclinical models of systemic sclerosis. J Invest Dermatol. 2017. doi: 10.1016\/j.jid.2017.03.032","DOI":"10.1016\/j.jid.2017.03.032"},{"issue":"10","key":"1356_CR16","doi-asserted-by":"publisher","first-page":"e109763","DOI":"10.1371\/journal.pone.0109763","volume":"9","author":"L Stawski","year":"2014","unstructured":"Stawski L, Haines P, Fine A, Rudnicka L, Trojanowska M. MMP-12 deficiency attenuates angiotensin II-induced vascular injury, M2 macrophage accumulation, and skin and heart fibrosis. PLoS One. 2014;9(10):e109763.","journal-title":"PLoS One"},{"issue":"4","key":"1356_CR17","doi-asserted-by":"publisher","first-page":"R194","DOI":"10.1186\/ar4028","volume":"14","author":"L Stawski","year":"2012","unstructured":"Stawski L, Han R, Bujor AM, Trojanowska M. Angiotensin II induces skin fibrosis: a novel mouse model of dermal fibrosis. Arthritis Res Ther. 2012;14(4):R194.","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"1356_CR18","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s11095-016-1918-0","volume":"33","author":"MC Brenner","year":"2016","unstructured":"Brenner MC, Krzyzanski W, Chou JZ, Signore PE, Fung CK, Guzman D, et al. FG-3019, a human monoclonal antibody recognizing connective tissue growth factor, is subject to target-mediated drug disposition. Pharm Res. 2016;33(8):1833\u201349.","journal-title":"Pharm Res"},{"issue":"5","key":"1356_CR19","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1183\/13993003.01030-2015","volume":"47","author":"G Raghu","year":"2016","unstructured":"Raghu G, Scholand MB, de Andrade J, Lancaster L, Mageto Y, Goldin J, et al. FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis. Eur Respir J. 2016;47(5):1481\u201391.","journal-title":"Eur Respir J"},{"issue":"30","key":"1356_CR20","doi-asserted-by":"publisher","first-page":"12325","DOI":"10.1073\/pnas.1300415110","volume":"110","author":"A Neesse","year":"2013","unstructured":"Neesse A, Frese KK, Bapiro TE, Nakagawa T, Sternlicht MD, Seeley TW, et al. CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer. Proc Natl Acad Sci U S A. 2013;110(30):12325\u201330.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"1356_CR21","doi-asserted-by":"publisher","first-page":"4938","DOI":"10.1093\/hmg\/ddt352","volume":"22","author":"MG Morales","year":"2013","unstructured":"Morales MG, Gutierrez J, Cabello-Verrugio C, Cabrera D, Lipson KE, Goldschmeding R, et al. Reducing CTGF\/CCN2 slows down mdx muscle dystrophy and improves cell therapy. Hum Mol Genet. 2013;22(24):4938\u201351.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"1356_CR22","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1038\/jid.2011.63","volume":"131","author":"T Hattori","year":"2011","unstructured":"Hattori T, Stawski L, Nakerakanti SS, Trojanowska M. Fli1 is a negative regulator of estrogen receptor \u03b1 in dermal fibroblasts. J Invest Dermatol. 2011;131(7):1469\u201376.","journal-title":"J Invest Dermatol"},{"key":"1356_CR23","doi-asserted-by":"crossref","unstructured":"Peoples C, Medsger TA, Lucas M, Rosario BL, Feghali-Bostwick CA. Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes. J scleroderma relat disord. 2016;1(2):204\u201312.","DOI":"10.5301\/jsrd.5000209"},{"issue":"9","key":"1356_CR24","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1182\/blood-2014-05-378638","volume":"124","author":"TA Springer","year":"2014","unstructured":"Springer TA. von Willebrand factor, Jedi knight of the bloodstream. Blood. 2014;124(9):1412\u201325.","journal-title":"Blood"},{"issue":"3","key":"1356_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1042\/CS20140264","volume":"128","author":"S Kubota","year":"2015","unstructured":"Kubota S, Takigawa M. Cellular and molecular actions of CCN2\/CTGF and its role under physiological and pathological conditions. Clin Sci (Lond). 2015;128(3):181\u201396.","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"1356_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1755-1536-4-4","volume":"4","author":"Q Wang","year":"2011","unstructured":"Wang Q, Usinger W, Nichols B, Gray J, Xu L, Seeley TW, et al. Cooperative interaction of CTGF and TGF-\u03b2 in animal models of fibrotic disease. Fibrogenesis Tissue Repair. 2011;4(1):4.","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"4","key":"1356_CR27","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/imm.12215","volume":"141","author":"A Charrier","year":"2014","unstructured":"Charrier A, Chen R, Kemper S, Brigstock DR. Regulation of pancreatic inflammation by connective tissue growth factor (CTGF\/CCN2). Immunology. 2014;141(4):564\u201376.","journal-title":"Immunology"},{"issue":"7","key":"1356_CR28","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1681\/ASN.2008090999","volume":"20","author":"E Sanchez-Lopez","year":"2009","unstructured":"Sanchez-Lopez E, Rayego S, Rodrigues-Diez R, Rodriguez JS, Rodrigues-Diez R, Rodriguez-Vita J, et al. CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-kappaB. J Am Soc Nephrol. 2009;20(7):1513\u201326.","journal-title":"J Am Soc Nephrol"},{"key":"1356_CR29","doi-asserted-by":"crossref","unstructured":"Bickelhaupt S, Erbel C, Timke C, Wirkner U, Dadrich M, Flechsig P, et al. Effects of CTGF blockade on attenuation and reversal of radiation-induced pulmonary fibrosis. J Natl Cancer Inst. 2017;109(8):djw339.","DOI":"10.1093\/jnci\/djw339"},{"issue":"6","key":"1356_CR30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11906-014-0431-2","volume":"16","author":"AC Montezano","year":"2014","unstructured":"Montezano AC, Nguyen Dinh Cat A, Rios FJ, Touyz RM. Angiotensin II and vascular injury. Curr Hypertens Rep. 2014;16(6):431.","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"1356_CR31","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/art.37705","volume":"65","author":"S Serrati","year":"2013","unstructured":"Serrati S, Chilla A, Laurenzana A, Margheri F, Giannoni E, Magnelli L, et al. Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)\/transforming growth factor \u03b2-dependent mesenchymal-to-mesenchymal transition. Arthritis Rheum. 2013;65(1):258\u201369.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1356_CR32","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1165\/rcmb.2011-0023OC","volume":"45","author":"D Alapati","year":"2011","unstructured":"Alapati D, Rong M, Chen S, Hehre D, Rodriguez MM, Lipson KE, et al. Connective tissue growth factor antibody therapy attenuates hyperoxia-induced lung injury in neonatal rats. Am J Respir Cell Mol Biol. 2011;45(6):1169\u201377.","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1356-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-017-1356-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1356-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T13:50:02Z","timestamp":1589550602000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-017-1356-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,13]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1356"],"URL":"https:\/\/doi.org\/10.1186\/s13075-017-1356-3","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,13]]},"assertion":[{"value":"14 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"134"}}